MICROBALIFESCIENCES ORDINARY (MAP) Short Interest
MICROBALIFESCIENCES ORDINARY (ASX:MAP) had 0.10% of shares reported as short positions as of 16 July 2026, representing 700,000 shares. MICROBALIFESCIENCES ORDINARY operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Microba Life Sciences
Microba Life Sciences is a pioneering company in the health care sector, specializing in advanced microbiome analysis technology. Their innovative approach provides deep insights into gut health, enabling precision diagnostics and personalized treatment plans. With a strong focus on scientific rigor and evidence-based solutions, Microba is positioned as a leader in microbiome research and diagnostics.
Short position
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4MAP intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Microba Life Sciences
Latest MAP news
All news- Microba (ASX:MAP) core testing revenue jumps 92% as the break-even math finally clicks - Stocks Down Under
googlenews
- Microba Life Sciences Announces Q4 FY26 Report Release and Investor Webinar on 16 July 2026
kalkine
- Change in substantial holding
asx
- Details of Q4 FY26 Quarterly Report, Appendix 4C & Webinar
asx
- Ceasing to be a substantial holder
asx
About
More Health Care Equipment & Services Stocks
Other shorted stocks in this sector
Be the first to discuss MAP
Start a research thread or post the first pulse update